Publications by authors named "Saptarshi Chaterjee"
Article Synopsis
- The phase 2 chronic pain master protocol (CPMP) aims to improve the research and development of new pain medications by efficiently testing various drugs across three types of pain: nociceptive, neuropathic, and mixed pain.
- The study is designed with predetermined statistical methods to optimize results and was accepted by the FDA for its innovative approach, which also minimizes the exposure of participants to placebo and reduces overall sample sizes.
- This protocol allows for simultaneous evaluation of multiple pain treatments, direct comparisons of their effectiveness, and faster clinical study processes, ultimately leading to a more effective assessment of new pain therapies.
